REG - Integrated Diag Hdgs - Publication of Circular and Notice of EGM

Integrated Diagnostics HoldingsAnnouncement

01/07/2024 15:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240701:nRSA6623Ua&default-theme=true

RNS Number : 6623U  Integrated Diagnostics Holdings PLC  01 July 2024

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN, INTO OR
FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE
RELEVANT LAWS OF SUCH JURISDICTION.

 

THIS ANNOUNCEMENT IS FOR INFORMATION PURPOSES ONLY AND IS NOT AN OFFER OF
SECURITIES IN ANY JURISDICTION.

 

Publication of Circular and Notice of Extraordinary General Meeting

 

1 July 2024

 

Further to the announcement made on 27 June 2024 (RNS: 0638U) by Integrated
Diagnostics Holdings plc (the "Company"), the Company announces that it has
today published a circular (the "Circular") containing further details of the
relevant shareholder resolutions to be considered and, if thought fit,
approved at an Extraordinary General Meeting of the Company to be convened
(the "EGM") and the notice of the EGM (the "Notice of EGM").

 

The EGM will be held on Thursday, 18 July 2024 at 1.00 pm (British Summer Time
("BST")) / 3.00 pm local time (Eastern European Summer Time ("EEST")) at the
Headquarters of Integrated Diagnostics Holdings plc, Building B216-F7, Smart
Village, Giza, Egypt.

 

If you are unable to attend the EGM but would like to vote on the resolutions,
kindly request to submit your proxy vote online at
https://www.signalshares.com/ (https://www.signalshares.com/) or via CREST in
accordance with the instructions set out in note 2 of the Explanatory Notes to
the Notice of EGM. Shareholders are strongly encouraged to submit their proxy
votes online at  https://www.signalshares.com/
(https://www.signalshares.com/)  or via CREST where applicable.  Proxy votes
must be received by 1.00 pm (BST) / 3.00 pm local time (EEST) on Tuesday, 16
July 2024.

The Board of Directors of the Company (the "Board") remains keen to encourage
engagement with shareholders. To that end, the Board would like to invite
questions from shareholders in advance of and during the EGM. Should
shareholders wish to submit questions to the Board prior to the deadline for
proxy voting they can do so, and these will be responded to on an individual
basis. In addition, the Board will offer shareholders the opportunity to dial
into the EGM, at which time they can also submit questions to the Board.

Shareholders wishing to access the dial-in facility or submit questions are
asked to email Tarek Yehia at tarek.yehia@idh.com
(mailto:tarek.yehia@idh.com) by close of business on Thursday, 11 July 2024.

A copy of the Circular which contains the Notice of EGM will shortly be
available on the Company's website: https://www.idhcorp.com/
(https://www.idhcorp.com/) and for inspection at the National Storage
Mechanism: https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

 

For further information please contact:

 

Integrated Diagnostics Holdings plc

Tarek Yehia

Investor Relations Director

T: +20 (0)2 3332 1126 | M: +20 10 6882 6678 | tarek.yehia@idhcorp.com
(mailto:tarek.yehia@idhcorp.com)

 

Company Secretary

Company Matters

IDHLondon@linkgroup.co.uk (mailto:IDHLondon@linkgroup.co.uk)

 

-Ends-

 

Important disclaimers (including in relation to securities law restrictions)

 

This announcement is for information purposes only and is not intended to and
does not constitute or form part of an investment recommendation or any offer
to buy or sell or subscribe for or any invitation to buy, sell or subscribe
for any securities in any jurisdiction.

 

This announcement may contain certain forward-looking statements. A
forward-looking statement is any statement that does not relate to historical
facts and events, and can be identified by the use of such words and phrases
as "according to estimates", "aims", "anticipates", "assumes", "believes",
"could", "estimates", "expects", "forecasts", "intends", "is of the opinion",
"may", "plans", "potential", "predicts", "projects", "should", "to the
knowledge of", "will", "would" or, in each case their negatives or other
similar expressions, which are intended to identify a statement as
forward-looking. This applies, in particular, to statements containing
information on future financial results, plans, or expectations regarding
business and management, future growth or profitability and general economic
and regulatory conditions and other matters affecting the Company and its
subsidiaries (the "Group").

 

Forward-looking statements reflect the current views of the Group's management
("Management") on future events, which are based on the assumptions of the
Management and involve known and unknown risks, uncertainties and other
factors that may cause the Group's actual results, performance or achievements
to be materially different from any future results, performance or
achievements expressed or implied by these forward-looking statements. The
occurrence or non-occurrence of an assumption could cause the Group's actual
financial condition and results of operations to differ materially from, or
fail to meet expectations expressed or implied by, such forward-looking
statements.

 

The Group's business is subject to a number of risks and uncertainties that
could also cause a forward-looking statement, estimate or prediction to differ
materially from those expressed or implied by the forward-looking statements
contained in this announcement. The information, opinions and forward-looking
statements contained in this announcement speak only as at its date and are
subject to change without notice. Save as required by applicable law, the
Group does not undertake any obligation to review, update, confirm or to
release publicly any revisions to any forward-looking statements to reflect
events that occur or circumstances that arise in relation to the content of
this announcement.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  CIRUAOSRSKUBRAR